Dr. Zelnak is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
5670 Peachtree Dunwoody Road
Suite 1100
Atlanta, GA 30342Phone+1 404-851-2300
Education & Training
- Emory University School of MedicineFellowship, Hematology and Medical Oncology, 2003 - 2007
- Emory University School of MedicineResidency, 2001 - 2003
- Emory University School of MedicineClass of 2001
Certifications & Licensure
- GA State Medical License 2003 - 2025
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 39 citationsRandomized Phase II Trial of Endocrine Therapy With or Without Ribociclib After Progression on Cyclin-Dependent Kinase 4/6 Inhibition in Hormone Receptor-Positive, Hum...Kevin Kalinsky, Melissa K Accordino, Codruta Chiuzan, Prabhjot S Mundi, Elizabeth Sakach
Journal of Clinical Oncology. 2023-08-20 - 50 citationsPhase I/II Trial of Exemestane, Ribociclib, and Everolimus in Women with HR+/HER2- Advanced Breast Cancer after Progression on CDK4/6 Inhibitors (TRINITI-1).Aditya Bardia, Sara A. Hurvitz, Angela DeMichele, Amy S. Clark, Amelia Zelnak
Clinical Cancer Research. 2021-08-01 - 10 citationsPreservation of quality of life in patients with human epidermal growth factor receptor 2–positive metastatic breast cancer treated with tucatinib or placebo when adde...Volkmar Mueller, Andrew M Wardley, Elisavet Paplomata, Erika Hamilton, Amelia Zelnak
European Journal of Cancer. 2021-06-29
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: